0% found this document useful (0 votes)
22 views58 pages

MD

Muscular dystrophy is a heterogeneous group of inherited disorders characterized by progressive degenerative muscle weakness and loss of muscle tissue. The document discusses several types including Duchenne muscular dystrophy, Becker muscular dystrophy, limb-girdle muscular dystrophy, facioscapulohumeral muscular dystrophy, congenital muscular dystrophy, and myotonic muscular dystrophy.

Uploaded by

Shivangi
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
22 views58 pages

MD

Muscular dystrophy is a heterogeneous group of inherited disorders characterized by progressive degenerative muscle weakness and loss of muscle tissue. The document discusses several types including Duchenne muscular dystrophy, Becker muscular dystrophy, limb-girdle muscular dystrophy, facioscapulohumeral muscular dystrophy, congenital muscular dystrophy, and myotonic muscular dystrophy.

Uploaded by

Shivangi
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 58

MUSCULAR

DYSTROPHY
• Causes
• Inheritance
• Dominant genes
• Recessive gene
Depends on the age when symptoms appear, and the
types of symptoms that develop.
• Risk
• Because these are inherited disorders, risk
include a family history of muscular dystrophy
● How Many People Are Affected
● It is estimated that between 50,000 -250,000
are affected annually. 1 per 3500 live male births
• Muscular dystrophy is a
heterogeneous group of inherited
by progressive
disorders degenerative muscle
recognized
weakness and loss of muscle tissue
(started in childhood).
• Affect muscles strength and action.
• Generalized or localized.
• Skeletal muscle and other organs
may involve

• Limitation: Difficulties with walking or Maintaining posture,


Muscle spasms. Neurological, Behavioral, Cardiac, or other
Functional limitations.
Classification
• Sex-linked: DMD, BMD,
EDMD
• Autosomal recessive:
LGMD, infantile FSHD
• Autosomal dominant: FSHD,
distalMD, ocular
MD, oculopharyngeal MD.
Duchenne Muscular Dystrophy

Guillaume Benjamin Amand Duchenne


(French neurologist, 1860s)
• Etiology
▫ single gene defect
▫ Xp21.2 region
▫ absent dystrophin
• Most
common
• male,
Turner
syndrome
• 1:3500live
male
birth
• 1/3
Clinical manifestation
• Onset : age 3-6
years
• Progressive
weakness
• Pseudohypertrophy
of calf muscles
• Spinal deformity
• Cardiopulmonary
involvement
• Mild - moderate
MR
Natural history

• Progress slowly and


continuously
• muscle weakness
▫ lower --> upper
extremities
• unable to ambulate: 10
year (7-12)
• death from pulmonary/
cardiac failure: 2-3rd de
cade
Pseudohypertrhophy of calf muscle, Tip toe gait
forward tilt of pelvis, compensatory lordosis
Disappearance of
lordosis while sitting
DMD: Diagnosis
• Gait

• Increase CPK
Absent DTR
• Ober test (200x)
• Thomas test • Myopathic change in
• Meyeron sign - child EMG
slips through truncal Bx: m. degeneration
grasp • Immunoblotting:
• Macroglossia Absence dystrophin
• Myocardial deterioration
• IQ ~ 80 • DNA mutation
analysis
Becker Muscular Dystrophy

Peter Emil Becker


(German doctor, 1950s)
• Milder version of
DMD
• Etiology
▫ single gene defect
▫ short arm X
chromosome
▫ altered size &
decreased amount
of dystrophin
Clinical features
• Less common
▫ 1: 30000 live male birth
• Less severe
• Family history: atypical MD
• Similar & less severe than DMD
• Onset: age > 7 years
• Pseudohypertrophy of calf
• Equinous and varus foot
• High rate of scoliosis
• Less frequent cardiac involvement
Diagnosis
• The same as DMD
• Increase CPK (<200x)
• Decrease dystrophin and/or altered size
Natural history
▫ Slower progression
▫ ambulate until adolescence
▫ longer life expectancy
Treatment
▫ the same as in DMD
▫ forefoot equinous: plantar release, midfoot dorsal-
Emery-Dreifuss Muscular Dystrophy
• Etiology
▫ X-linked recessive
▫ Xq28
▫ Emerinprotein (in nuclear
membrane)
• Epidemiology
▫ Male: typical phenotype
▫ Female carrier: partial
• Clinical Features
▫ Muscle weakness
Scoliosis: common, low incidence of
progression
Bradycardia, 1st degree AV block  sudden
death
• Natural history
▫ 1st 10 y: mild
weakness
▫ Later: contracture,
• Diagnosis cardiac abnormality
▫ Gower’s sign ▫ 5th-6th decade: can
ambulate
▫ Mildly/moderately
elevated CPK ▫ Poor prognosis in
obesity, untreated
▫ EMG: myopathic equinus
contractures.
Treatment
• Physical therapy
▫ Prevent contracture: neck, elbow, paravertebral
muscles
▫ For slow progress elbow flexion contracture
• Soft tissue contracture
▫ Achillis lengthening, posterior ankle capsulotomy +
anterior transfer of tibialis posterior
• Spinal stabilization
▫ For curve > 40 degrees
• Cardiologic intervention
Limb - Girdle Muscular
Dystrophy
• Etiology
▫ Autosomal recessive at chromosome
15q
▫ Autosomal dominant at 5q
• Epidemiology
▫ Common
• Clinical
manifestation
▫ Age of onset:
3rd decade
▫ Initial:
pelvic/shoulder m.
(proximal to distal)
▫ Similar
distribution as DMD
Hemiatroph
y
• Classification
▫ Pelvic girdle type

 common

▫ Scapulohumeral
type • Diagnosis
 rare ▫ Same clinical as
DMD/BMD carriers
▫ Moderately elevated
CPK
• Natural history
▫ Slow progression
▫ After onset > 20 y:
contracture &
disability
▫ Rarely significant
scoliosis

•T
r
e
a
Fascioscapulohumeral Muscular
Dystrophy
• Etiology • Clinical
manifestation
▫ Autosomal dominant
▫ Age of onset: late
▫ Gene defect (FRG1) childhood/ early adult
▫ No cardiac, CNS
▫ Chromosome 4q35 involvement
• Epidemiology ▫ Winging scapula decreased
▫ Markedly
▫ Female > male flexion &
shoulder
abduction
▫ Horizontal clavicles
• Muscle weakness
▫ face, shoulder, upper arm

• Sparing
▫ Deltoid
▫ Distal pectoralis major
▫ Erector spinae
• “Popeye”
appearance
▫ Lack of
▫facial mobility
Incomplete eye
closure
▫ Pouting lips
▫ Transverse
smile
▫ Absence of
eye and forehead
wrinkles

POPEYE ARMS
• Diagnosis
▫ PE, muscle biopsy

▫ Normal serum • Treatment


CPK
▫ Posterior
• Natural scpulocostal fusion/
history stabilization
▫ Slow (scapuloplexy)
progression
▫ Face, shoulder
Distal Muscular Dystrophy

• Autosomal dominant trait


• Rare
• Dysferlin (mb prot) defect
• Age of onset: after 45 yrs
• Initial involvement:
intrinsic hands, claves,
tibialis posterior
• Spread proximally
• Normal sensation
Congenital Muscular
Dystrophy
• Etiology
▫ Autosomal recessive
▫ Integrin, fugutin
defect
• Epidemiology
▫ Rare
▫ Both male and female
• Classification
▫ Merosin-negative
▫ Merosin-positive
Clinical manifestation

• Stiffness of joint
• Congenital hip
dislocation,
subluxation
• Achillis tendon
contracture, talipes
equinovarus
• Scoliosis
Diagnosis
Muscle Bx: Perimysial and endomysial fibrosis
Treatment
Physical therapy
Orthosis
Soft tissue release
Osteotomy
Oculopharyngeal Muscular
Dystrophy
• Autosomal dominant
• Age of onset: 3rd decade
• Ptosis in middle life
• Pharyngeal involvement
▫ Dysarthria
▫ Dysphasia
▫ Repetitive regurgitation
▫ Frequently choking
Myotonic Muscular Dystrophy

HATCHET FACIES
`Classical form' of the disease is seen in
adolescent or early adult life with variable
presenting features.
• Muscular weakness,
•myotonia,
•mental retardation,
•cataract,
•neonatal problems
•18% remain asymptomatic.
Summary
Clinical DMD LGMD FSMD DD CMD

Incidence common less Not common Rare Rare

Age of 3-6 y 2nd decade 2nd decade 20-77 y At/ after birth
onset

Sex Male Either sex M = F Either sex Both

Inheritance Sex- AR, rare AD AD AD Unknown


linked
recessive
Muscle Proximal to Proximal to Face & Distal Generalized
involve distal distal shoulder to
. pelvic

Muscle Leg, hand, Upper ex, Back ext, Proximal -


spread until arm, face, calf hip abd,
late quad
Clinical DMD LGMD FSMD DD CMD
Pseudo 80% < 33% Rare no No
hypertrophy calf

Contracture Common Late Mild, late Mild, late Severe

Scoliosis Common, late Late - - ?


Kyphoscoliosis

Heart Hypertroph Very rare Very rare Very rare Not


yt observe
achycardia d

Intellectual decrease Normal Normal Normal ?

Course Stead, rapid Slow Insidious benign Steady


Treatment
is generally aimed at
controlling the onset of
symptoms to maximize the
quality of life.

You might also like